Dr Aristeidis Chaidos


  • Fee assured

You'll need to contact this healthcare professional to check their availability

Specialises in

  • Haemato-oncology

About me

Dr Aristeidis Chaidos is a Consultant Haematologist and Honorary Senior Clinical Lecturer at Hammersmith Hospital, with clinical and research interest in multiple myeloma, lymphomas and haematopoietic stem cell transplantation. He completed his training in haematology and PhD research on multiple myeloma at the University of Ioannina, Greece in 2005. He was then trained in haematopoietic stem cell transplantation at Hammersmith Hospital (2005 – 2007) and later joined Professor Karadimitris’ laboratory for post-doctoral research on multiple myeloma.
Dr Chaidos has a strong research interest in multiple myeloma propagating cells, epigenetic mechanisms in drug resistance and novel therapies. He is a principal investigator and co-investigator in several clinical studies on multiple myeloma and lymphomas.

Areas of interest

Stem cells transplantation

My qualifications & training
Consultant's practices
Information for healthcare professionals

Information for healthcare professionals (Bupa patients only, last 12 months)

Procedures completed

  • X0004

    Clinical supervision and planning for delivery of chemotherapy cycle 1 - 28 days - (5-50)

    Hammersmith Hospital (5-50)

  • X0003

    Clinical supervision and planning for delivery of chemotherapy cycle 1 - 21 days - (1-5)

    Hammersmith Hospital (1-5)

  • W3650

    Diagnostic aspiration and trephine biopsy of bone marrow, including analysis - (1-5)

    Hammersmith Hospital (1-5)

Report this page Edit details Print page

The information contained on Finder is submitted by consultants, therapists and healthcare services, and is declared by these third parties to be correct and compliant with the standards and codes of conduct specified by their relevant regulatory body. Bupa cannot guarantee the accuracy of all of the information provided.

You can find out more about the information on Finder and our website terms of use.